Cargando…

Low-Dose Naltrexone Co-Treatment in the Prevention of Opioid-Induced Hyperalgesia

Opioid-induced hyperalgesia (OIH) is characterized by a heightened sensitivity to pain that occurs in patients following opioid use. Prescription of opioids is currently the standard form of pain management for both neuropathic and nociceptive pain, due to the relief that patients typically report f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaheed, Gurneet, Manjooran, Anthony P, Reddy, Akshay J, Nawathey, Neel, Habib, Samuel, Brahmbhatt, Hetal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487298/ https://www.ncbi.nlm.nih.gov/pubmed/34646707 http://dx.doi.org/10.7759/cureus.17667

Ejemplares similares

A Review on the Role of Ethylenediaminetetraacetic Acid (EDTA) in the Treatment and Understanding of Psoriasis
por: Sunil, Amreen, et al.
Publicado: (2021)

An Investigation on the Preconditions and Diagnosis Methods for Alien Hand Syndrome
por: Pradhan, Aakash, et al.
Publicado: (2022)

The Effects of Low Dose Naltrexone on Opioid Induced Hyperalgesia and Fibromyalgia
por: Jackson, Daniel, et al.
Publicado: (2021)

Evaluating the Utilization of Ethylenediaminetetraacetic Acid as a Treatment Supplement for Gliomas
por: Ghauri, Muhammad S, et al.
Publicado: (2022)

Application of Anticonvulsants, Antiepileptic Drugs, and Vitamin C in the Treatment and Analysis of Batten Disease
por: Reddy, Shreya, et al.
Publicado: (2022)

Assessing the Efficacy of Alkylating Agent Regimens in the Treatment of Infantile Malignant Osteopetrosis: Cyclophosphamide, Busulfan, or Thiotepa
por: Wagh, Himanshu, et al.
Publicado: (2022)

Treatment of a Rare Case of Orbital Necrotizing Fasciitis Utilizing Negative Pressure Wound Therapy
por: Reddy, Akshay J, et al.
Publicado: (2021)

Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study
por: Micheli, Laura, et al.
Publicado: (2020)

Low-Dose Naltrexone in Rheumatological Diseases
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2023)

A Review of the Usage and Post-surgical Outcomes of Anesthesia for Laser In Situ Keratomileusis (LASIK) Procedure
por: Riazi Esfahani, Parsa, et al.
Publicado: (2022)

Naltrexone Implant for Opioid Use Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

Low-Dose Naltrexone for Pruritus in Systemic Sclerosis
por: Frech, Tracy, et al.
Publicado: (2011)

Low-dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis
por: Beltran Monasterio, Eduardo P
Publicado: (2019)

Treatment of psoriasis vulgaris using low-dose naltrexone
por: Bridgman, Alanna C., et al.
Publicado: (2018)

Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization
por: Toljan, Karlo, et al.
Publicado: (2018)

Reported Benefits of Low-Dose Naltrexone Appear to Be Independent of the Endogenous Opioid System Involving Proopiomelanocortin Neurons and β-Endorphin
por: Metz, Marissa J., et al.
Publicado: (2021)

Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy
por: Zashin, Scott
Publicado: (2019)

Low-dose naltrexone as a treatment for chronic fatigue syndrome
por: Bolton, Monica Jane, et al.
Publicado: (2020)

Effectiveness of Naltrexone in the Prevention of Delayed Respiratory Arrest in Opioid-Naive Methadone-Intoxicated Patients
por: Aghabiklooei, Abbas, et al.
Publicado: (2013)

Compulsive Sexual Behavior and Alcohol Use Disorder Treated With Naltrexone: A Case Report and Literature Review
por: Sultana, Tania, et al.
Publicado: (2022)

Opioid induced hyperalgesia in anesthetic settings
por: Lee, Hyeon Jeong, et al.
Publicado: (2014)

A narrative review on the effects of a ketogenic diet on patients with Alzheimer's disease
por: Tabaie, Ethan Ali, et al.
Publicado: (2021)

Low‐dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database
por: Raknes, Guttorm, et al.
Publicado: (2017)

An Analysis of the Usage of Retinal Imaging Technology in the Detection of Age-Related Macular Degeneration
por: Riazi Esfahani, Parsa, et al.
Publicado: (2023)

Comment on “Effectiveness of Naltrexone in the Prevention of Delayed Respiratory Arrest in Opioid-Naive Methadone-Intoxicated Patients”
por: Kessler, Benjamin D., et al.
Publicado: (2014)

Comment on “Effectiveness of Naltrexone in the Prevention of Delayed Respiratory Arrest in Opioid-Naive Methadone-Intoxicated Patients”
por: Aghabiklooei, Abbas, et al.
Publicado: (2015)

Pharmacological enhancement of naltrexone treatment for opioid dependence: a review
por: Mannelli, Paolo, et al.
Publicado: (2011)

Long-Acting Injectable Naltrexone for the Management of Patients with Opioid Dependence
por: Kjome, Kimberly L., et al.
Publicado: (2011)

Naltrexone extended-release injection: an option for the management of opioid abuse
por: Taylor, Robert, et al.
Publicado: (2011)

Anhedonia to music and mu-opioids: Evidence from the administration of naltrexone
por: Mallik, Adiel, et al.
Publicado: (2017)

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
por: Lie, Mitchell R. K. L., et al.
Publicado: (2018)

Low Dose Naltrexone and Lung Cancer: A Case Report and Discussion
por: Miskoff, Jeffrey A, et al.
Publicado: (2018)

A Systematic Review of the Usage of Rotigotine During Early and Advanced Stage Parkinson's
por: Rajendran, Avanthika, et al.
Publicado: (2023)

Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis
por: Ludwig, Michael D, et al.
Publicado: (2016)

Aticaprant (Clinically Developed Kappa-Opioid Receptor Antagonist) Combined With Naltrexone Prevents Alcohol “Relapse” Drinking
por: Zhou, Y, et al.
Publicado: (2022)

PM312. Combination of levo-tetrahydropalmatine and low dose naltrexone: a promising treatment for the prevention of cocaine relapse
por: Wang, Jia Bei, et al.
Publicado: (2016)

Kratom-induced transaminitis with subsequent precipitated opioid withdrawal following naltrexone
por: Jensen, Aimee N., et al.
Publicado: (2021)

Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats
por: Mattioli, Theresa-Alexandra M, et al.
Publicado: (2010)

The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review
por: Yang, Juan, et al.
Publicado: (2023)

Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa–associated refractory pruritus
por: LaMonica, Lauren C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o4o3bcj3k03kct6iaan7safomi